FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following mRNA Vaccination
Copy link
Facebook
Email
Notes
More

Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following mRNA Vaccination

Analysis of the Potential Pathogenic Mechanism(s) Based on Existing Literature not False Wikipedia Claims

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
Apr 05, 2024
∙ Paid
148

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following mRNA Vaccination
Copy link
Facebook
Email
Notes
More
19
14
Share
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

Recently I posted a paper from Choi et al regarding population based hematologic abnormalities in 4.2 million Koreans after COVID-19 vaccination. I wondered if any cases were very serious diagnoses like hematologic malignancies.

Gentilini et al published a case of acute lymphoblastic leukemia in a 38 year old woman with striking symptoms, blood tests, and bone marrow abnormalities after the second dose of the Pfizer/BioNTech Comirnaty mRNA COVID-19 vaccine. One of the clues was how sick the patient became after the second dose:

Keep reading with a 7-day free trial

Subscribe to FOCAL POINTS (Courageous Discourse) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More